With many diseases, there are opportunities to assess the genetics of a patient in a minimally invasive manner, such as:
- A blood draw
- Surface level tissue
- Fluid samplings
These samples can act as effective surrogates for monitoring drug activity and response in many diseases, including:
- Immunology
- Cardiovascular disease
- Oncology
Both efficacy and adverse events can be tracked. Tracking drug response over time will improve methods for selecting dose and assess the overall effectiveness of treatment quickly, which is a critical factor when it takes many months or longer to otherwise track the effectiveness of response.
